Tarsus Pharmaceuticals (TARS) Work In Process (2023 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Work In Process of $1.6 million for Q1 2026, up 113.61% year-over-year from $764000.0 in Q1 2025, and up 15.74% quarter-over-quarter from $1.4 million in Q4 2025.
Tarsus Pharmaceuticals (TARS) Work In Process (2023 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Work In Process rose 113.61% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 113.61% YoY), while the FY2025 annual figure was $1.4 million, up 129.64% from the prior year.
- Work In Process for Q1 2026 stood at $1.6 million, up from $1.4 million in the prior quarter.
- The five-year high for Work In Process was $1.6 million in Q1 2026, with the low at $392000.0 in Q4 2023.
- The 4-year median for Work In Process is $1.1 million (2024), against an average of $1.1 million.
- Peak annual rise in Work In Process reached 129.64% in 2025, while the deepest fall reached 37.12% in 2025.
- Tarsus Pharmaceuticals' Work In Process stood at $392000.0 in 2023, then surged by 56.63% to $614000.0 in 2024, then soared by 129.64% to $1.4 million in 2025, then rose by 15.74% to $1.6 million in 2026.
- Business Quant data shows TARS's Work In Process at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tarsus Pharmaceuticals | 2.99 Bn | 2.54 Bn | 161.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 764,000.00 |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 677,000.00 |
| Dec 31, 2023 | 392,000.00 |